Published in Neuroimage on September 28, 2009
Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol (2014) 1.56
Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. Proc Natl Acad Sci U S A (2010) 1.52
A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev (2013) 1.28
Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI. Neuroimage (2011) 1.04
Facing changes and changing faces in adolescence: a new model for investigating adolescent-specific interactions between pubertal, brain and behavioral development. Dev Cogn Neurosci (2011) 1.04
Testosterone-related cortical maturation across childhood and adolescence. Cereb Cortex (2012) 1.01
Measuring the effects of aging and sex on regional brain stiffness with MR elastography in healthy older adults. Neuroimage (2015) 0.94
The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review. Neuroradiology (2010) 0.93
Controversies about the enhanced vulnerability of the adolescent brain to develop addiction. Front Pharmacol (2013) 0.91
Postnatal brain development: structural imaging of dynamic neurodevelopmental processes. Prog Brain Res (2011) 0.90
Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. Int J Neuropsychopharmacol (2014) 0.89
The influence of sex steroids on structural brain maturation in adolescence. PLoS One (2014) 0.88
Increased medial temporal lobe and striatal grey-matter volume in a rare disorder of androgen excess: a voxel-based morphometry (VBM) study. Int J Neuropsychopharmacol (2010) 0.86
Sex-specific gray matter volume differences in females with developmental dyslexia. Brain Struct Funct (2013) 0.86
Asymmetry of cerebral gray and white matter and structural volumes in relation to sex hormones and chromosomes. Front Neurosci (2014) 0.81
Structural and functional correlates of epileptogenesis - does gender matter? Neurobiol Dis (2014) 0.80
Impact of sex and gonadal steroids on neonatal brain structure. Cereb Cortex (2013) 0.79
White matter microstructure in transsexuals and controls investigated by diffusion tensor imaging. J Neurosci (2014) 0.79
Gender differences of brain glucose metabolic networks revealed by FDG-PET: evidence from a large cohort of 400 young adults. PLoS One (2013) 0.79
Neural correlates of post-conventional moral reasoning: a voxel-based morphometry study. PLoS One (2015) 0.78
Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study. PLoS One (2013) 0.78
Post-adolescent developmental changes in cortical complexity. Behav Brain Funct (2014) 0.77
Gray Matter Features of Reading Disability: A Combined Meta-Analytic and Direct Analysis Approach(1,2,3,4). eNeuro (2016) 0.76
Sex differences in the neural substrates of spatial working memory during adolescence are not mediated by endogenous testosterone. Brain Res (2014) 0.76
Testosterone affects language areas of the adult human brain. Hum Brain Mapp (2016) 0.76
A quantitative and qualitative review of the effects of testosterone on the function and structure of the human social-emotional brain. Metab Brain Dis (2015) 0.76
Neural correlates of four broad temperament dimensions: testing predictions for a novel construct of personality. PLoS One (2013) 0.76
Sex-specific associations of testosterone with prefrontal-hippocampal development and executive function. Psychoneuroendocrinology (2016) 0.75
Male-to-female gender dysphoria: Gender-specific differences in resting-state networks. Brain Behav (2017) 0.75
Biological factors and age-dependence of primary motor cortex experimental plasticity. Neurol Sci (2015) 0.75
Sex differences in cortical thickness in middle aged and early old-aged adults: Personality and Total Health Through Life study. Neuroradiology (2013) 0.75
Correlations and anticorrelations in resting-state functional connectivity MRI: a quantitative comparison of preprocessing strategies. Neuroimage (2009) 4.88
The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int (2013) 2.73
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage (2011) 2.05
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry (2009) 1.87
Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology (2002) 1.82
Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med (2007) 1.77
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry (2006) 1.77
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry (2003) 1.66
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol (2007) 1.64
Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial. Br J Psychiatry (2004) 1.61
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry (2007) 1.60
Anger attacks in depression--evidence for a male depressive syndrome. Psychother Psychosom (2005) 1.55
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging (2008) 1.55
International Consensus Group on Bipolar I Depression Treatment Guidelines. J Clin Psychiatry (2004) 1.50
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.49
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract (2012) 1.49
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry (2013) 1.48
Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry (2006) 1.46
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry (2004) 1.44
The serotonin-1A receptor in anxiety disorders. Biol Psychiatry (2009) 1.40
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry (2002) 1.23
Differential modulation of the default mode network via serotonin-1A receptors. Proc Natl Acad Sci U S A (2012) 1.22
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry (2002) 1.19
The suppressive influence of SMA on M1 in motor imagery revealed by fMRI and dynamic causal modeling. Neuroimage (2007) 1.19
Fully exploratory network independent component analysis of the 1000 functional connectomes database. Front Hum Neurosci (2012) 1.18
Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol (2003) 1.17
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry (2011) 1.06
Bright-light therapy in the treatment of mood disorders. Neuropsychobiology (2011) 1.05
Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage (2009) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry (2002) 1.04
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. Int Clin Psychopharmacol (2007) 1.04
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry (2011) 1.03
Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci (2003) 1.03
Serotonin and molecular neuroimaging in humans using PET. Amino Acids (2011) 1.02
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci (2012) 1.02
Group ICA of resting-state data: a comparison. MAGMA (2010) 1.01
Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials. Psychother Psychosom (2015) 1.01
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry (2004) 0.99
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Neuropsychopharmacol (2007) 0.99
Meta-analysis: fact or fiction? How to interpret meta-analyses. World J Biol Psychiatry (2011) 0.99
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry (2005) 0.98
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology (2007) 0.98
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. Int Clin Psychopharmacol (2011) 0.97
Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs (2012) 0.96
Switching antidepressant class does not improve response or remission in treatment-resistant depression. J Clin Psychopharmacol (2011) 0.96
Comparing neural response to painful electrical stimulation with functional MRI at 3 and 7 T. Neuroimage (2013) 0.95
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling. Neuroimage (2012) 0.95
Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Psychopharmacology (Berl) (2002) 0.94
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol (2012) 0.94
A highly parallelized framework for computationally intensive MR data analysis. MAGMA (2011) 0.94
Recurrent brief depression revisited. Int Rev Psychiatry (2005) 0.93
Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology (2007) 0.93
Influence of fMRI smoothing procedures on replicability of fine scale motor localization. Neuroimage (2004) 0.93
Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa. Int J Eat Disord (2004) 0.93
Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. J Neurosci (2010) 0.93
Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage (2012) 0.92
Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum Brain Mapp (2009) 0.92
Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study. Epilepsy Behav (2010) 0.92
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. Int Clin Psychopharmacol (2009) 0.92
RESCALE: Voxel-specific task-fMRI scaling using resting state fluctuation amplitude. Neuroimage (2012) 0.91
The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol (2009) 0.91
Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. Int J Neuropsychopharmacol (2010) 0.91
Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. Neuroimage (2008) 0.90
White matter hyperintensities and chronicity of depression. J Psychiatr Res (2005) 0.90
Imaging treatment effects in depression. Rev Neurosci (2012) 0.90
A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients. Int J Psychiatry Clin Pract (2010) 0.90
Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berl) (2006) 0.90
Increased neural habituation in the amygdala and orbitofrontal cortex in social anxiety disorder revealed by FMRI. PLoS One (2012) 0.90
Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas. Neuroimage (2012) 0.90
Brightening depression. Science (2004) 0.89